Delivery Order SPE2DB20D2002-SPE2DB23FL53C

Award Date 7/17/23
Potential Completion Date 7/18/23
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,059 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets. The order, placed under an unspecified governmentwide acquisition contract vehicle, calls for the delivery of 30 bottles of the HIV/AIDS medication to a facility in Conshohocken, Pennsylvania by August 3, 2023. No subcontractors or set-aside designations were indicated. As a component...
The Defense Logistics Agency awarded a $3,218.90 delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The firm fixed price order is for 30 units of the HIV medication and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 9, 2023 to support DLA programs. No set aside designation or subcontractors were identified. The order was placed under an existing DLA pharmaceutical supply vehicle to...
The Defense Logistics Agency awarded a $4,151.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir tablets. The delivery order was issued under an existing prime vendor contract vehicle and calls for the delivery of a 30-day supply of the HIV medication to a Defense Logistics Agency location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with no mention of major...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,652 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets. The order, placed under an existing prime vendor contract vehicle, calls for the delivery of 30 bottles of the HIV/AIDS medication to a DLA facility in Conshohocken, Pennsylvania by July 12, 2023. No subcontractors or set-aside designations were indicated. The award supports DLA's...
The Defense Logistics Agency awarded a $188,460 delivery order to Amerisourcebergen Drug Corporation for the supply of emtricitabine-tenofovir disoproxil fumarate combination tablets. The firm fixed price order calls for the delivery of 200-300mg doses of the HIV/AIDS drug in unit-of-use packaging of 30 tablets. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from July 18 to July 19, 2023. No set aside provisions or...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,385 to Amerisourcebergen Drug Corporation for 200-300mg tablets of emtricitabine-tenofovir. The delivery order, issued under an unspecified governmentwide acquisition contract, calls for 30 units of the antiretroviral medication to be delivered to a facility in Conshohocken, Pennsylvania between July 17-18, 2023. No subcontractors or set aside designations were identified....
The Defense Logistics Agency awarded a $692.76 delivery order to Amerisourcebergen Drug Corporation for the provision of 200-300mg emtricitabine-tenofovir combination tablets. The firm fixed price order calls for the delivery of 30 units of the HIV treatment medication to a location in Conshohocken, Pennsylvania, with performance required between July 17-18, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,726 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets in unit-of-use packaging of 30 tablets. Performance will occur at the prime contractor's facility located in Conshohocken, Pennsylvania over a period of one day from September 18 through September 19, 2023. The delivery order was issued under an existing...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $12,937 to Amerisourcebergen Drug Corporation for the supply of 200-300mg Emtricitabine-Tenofovir disoproxil fumarate combination tablets in unit dose packages of 30 tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 25, 2023 under the terms of the order. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $720.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of 30 tablets to a facility in Conshohocken, Pennsylvania by July 25, 2023. As the logistics and procurement agency of the U.S. Department of Defense, the Defense Logistics Agency supports...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB23FL53C
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,225 to Amerisourcebergen Drug Corporation for the supply of 200-300mg emtricitabine-tenofovir combination tablets. The order, placed under an unspecified government-wide acquisition contract vehicle, calls for the delivery of 30 units of the HIV/AIDS drug to a facility in Conshohocken, Pennsylvania by July 18, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports DLA's mission to provide critical medicines to military treatment facilities and beneficiaries. No subcontractors or set-aside designations were identified.

Generated 12/24/23, 9:15 PM